These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31516163)

  • 1. WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT?
    Bozkurt B; Kamat IS
    Trans Am Clin Climatol Assoc; 2019; 130():41-50. PubMed ID: 31516163
    [No Abstract]   [Full Text] [Related]  

  • 2. Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
    Kimura K; Momose T; Hasegawa T; Morita T; Misawa T; Motoki H; Izawa A; Ikeda U
    J Cardiol; 2016 May; 67(5):399-405. PubMed ID: 26692119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
    Rossignol P; Dobre D; McMurray JJ; Swedberg K; Krum H; van Veldhuisen DJ; Shi H; Messig M; Vincent J; Girerd N; Bakris G; Pitt B; Zannad F
    Circ Heart Fail; 2014 Jan; 7(1):51-8. PubMed ID: 24297687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
    Butler J; Forman DE; Abraham WT; Gottlieb SS; Loh E; Massie BM; O'Connor CM; Rich MW; Stevenson LW; Wang Y; Young JB; Krumholz HM
    Am Heart J; 2004 Feb; 147(2):331-8. PubMed ID: 14760333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
    Maeder MT; Rickli H; Pfisterer ME; Muzzarelli S; Ammann P; Fehr T; Hack D; Weilenmann D; Dieterle T; Kiencke S; Estlinbaum W; Brunner-La Rocca HP;
    Am Heart J; 2012 Mar; 163(3):407-14, 414.e1. PubMed ID: 22424011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alkaline phosphatase as a predictor of worsening renal function in patients with acute decompensated heart failure.
    Yamazoe M; Mizuno A; Nishi Y; Niwa K; Isobe M
    J Cardiol; 2016 May; 67(5):412-7. PubMed ID: 26363819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.
    Fudim M; Loungani R; Doerfler SM; Coles A; Greene SJ; Cooper LB; Fiuzat M; O'Connor CM; Rogers JG; Mentz RJ
    Am Heart J; 2018 Oct; 204():163-173. PubMed ID: 30121018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between worsening renal function and persistent congestion in acute decompensated heart failure.
    Wattad M; Darawsha W; Solomonica A; Hijazi M; Kaplan M; Makhoul BF; Abassi ZA; Azzam ZS; Aronson D
    Am J Cardiol; 2015 Apr; 115(7):932-7. PubMed ID: 25700802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of congestion with worsening renal function in acute decompensated heart failure according to age.
    Odajima S; Fujimoto W; Kuroda K; Yamashita S; Imanishi J; Iwasaki M; Todoroki T; Okuda M; Hayashi T; Konishi A; Shinohara M; Toh R; Hirata KI; Tanaka H
    ESC Heart Fail; 2022 Dec; 9(6):4250-4261. PubMed ID: 36113882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradox of transient worsening renal function in patients with acute heart failure: the role of B-type natriuretic peptide and diuretic response.
    Ruocco G; Nuti R; Giambelluca A; Evangelista I; De Vivo O; Daniello C; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):851-858. PubMed ID: 28704280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Voors AA; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Ter Maaten JM; Ng L; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M
    Eur J Heart Fail; 2016 Jun; 18(6):716-26. PubMed ID: 27126231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of worsening renal function related to medication in heart failure.
    Brunner-La Rocca HP; Knackstedt C; Eurlings L; Rolny V; Krause F; Pfisterer ME; Tobler D; Rickenbacher P; Maeder MT;
    Eur J Heart Fail; 2015 Feb; 17(2):159-68. PubMed ID: 25808849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.
    Kula AJ; Hanberg JS; Wilson FP; Brisco MA; Bellumkonda L; Jacoby D; Coca SG; Parikh CR; Tang WHW; Testani JM
    Circ Heart Fail; 2016 Jan; 9(1):e002333. PubMed ID: 26699390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data.
    Metra M; Cotter G; Senger S; Edwards C; Cleland JG; Ponikowski P; Cursack GC; Milo O; Teerlink JR; Givertz MM; O'Connor CM; Dittrich HC; Bloomfield DM; Voors AA; Davison BA
    Circ Heart Fail; 2018 May; 11(5):e004644. PubMed ID: 29748350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction.
    Clark H; Krum H; Hopper I
    Eur J Heart Fail; 2014 Jan; 16(1):41-8. PubMed ID: 24453097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization.
    Testani JM; Cappola TP; McCauley BD; Chen J; Shen J; Shannon RP; Kimmel SE
    Am Heart J; 2011 May; 161(5):944-9. PubMed ID: 21570527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
    Brisco MA; Zile MR; Hanberg JS; Wilson FP; Parikh CR; Coca SG; Tang WH; Testani JM
    J Card Fail; 2016 Oct; 22(10):753-60. PubMed ID: 27374839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal interactions: insights from the ESCAPE trial.
    Nohria A; Hasselblad V; Stebbins A; Pauly DF; Fonarow GC; Shah M; Yancy CW; Califf RM; Stevenson LW; Hill JA
    J Am Coll Cardiol; 2008 Apr; 51(13):1268-74. PubMed ID: 18371557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.